WEBULL
News
VALN
9.68
+1.99%
0.19
Weekly Report: what happened at VALN last week (0202-0206)?
Weekly Report · 19h ago
Valneva SE Reports 173,877,420 Issued Shares and 189,607,235 Voting Rights
Reuters · 3d ago
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 5d ago
Valneva and Instituto Butantan Launch Pilot Chikungunya Vaccination Campaign in Brazil
TipRanks · 6d ago
Valneva SE and Instituto Butantan Launch Chikungunya Vaccine Pilot in Brazil
Reuters · 6d ago
Valneva SE startet Impfstoff-Partnerschaft mit Instituto Butantan gegen Chikungunya
Reuters · 6d ago
VALNEVA AND INSTITUTO BUTANTAN ANNOUNCE INITIATION OF A PILOT VACCINATION CAMPAIGN IN BRAZIL WITH SINGLE-SHOT CHIKUNGUNYA VACCINE IXCHIQ®
Reuters · 6d ago
Weekly Report: what happened at VALN last week (0126-0130)?
Weekly Report · 02/02 10:35
Weekly Report: what happened at VALN last week (0119-0123)?
Weekly Report · 01/26 10:35
Valneva Steps Back From US Approval Bid For Chikungunya Vaccine
Benzinga · 01/20 20:58
Valneva Withdraws U.S. IXCHIQ Chikungunya Filings After FDA Clinical Hold
TipRanks · 01/20 15:17
Valneva, Tesla And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Benzinga · 01/20 13:05
BUZZ-Valneva shares fall after it withdraws chikungunya vaccine applications in US
Reuters · 01/20 08:31
Reported Monday, Valneva Withdraws IXCHIQ Chikungunya Vaccine BLA And IND In The US Following FDA Suspension And New Serious Adverse Event Review
Benzinga · 01/20 07:25
Valneva Withdraws Chikungunya Vaccine IXCHIQ Applications In U.S. Amid FDA Suspension
NASDAQ · 01/20 03:24
Valneva withdraws BLA, IND application for Ixchiq in U.S.
TipRanks · 01/19 19:15
Valneva Withdraws U.S. Applications for Chikungunya Vaccine After FDA Suspension
Reuters · 01/19 17:00
VALNEVA SE - INTENDS TO MOVE FORWARD WITH ITS PLANNED POST-MARKETING CLINICAL ACTIVITIES, SUBJECT TO FURTHER DISCUSSIONS WITH RELEVANT REGULATORY AUTHORITIES
Reuters · 01/19 17:00
Weekly Report: what happened at VALN last week (0112-0116)?
Weekly Report · 01/19 10:42
Weekly Report: what happened at VALN last week (0105-0109)?
Weekly Report · 01/12 10:41
More
Webull provides a variety of real-time VALN stock news. You can receive the latest news about Valneva Se through multiple platforms. This information may help you make smarter investment decisions.
About VALN
Valneva SE is a France-based company that specializes in the development, manufacture and commercialization of vaccines to protect people from infectious diseases through preventative medicine. The Company's portfolio includes two commercial vaccines for travelers: IXIARO/JESPECT, for the prevention of Japanese Encephalitis, and DUKORAL, which is indicated for the prevention of cholera and, in some countries, prevention of diarrhea caused by Enterotoxigenic escherichia coli (ETEC). The Company has also vaccines in development, including candidates against Lyme disease, COVID-19 and chikungunya. Its technologies and services segment cooperates with various pharmaceutical companies using its platform: EB66 vaccine production cell line and IC31 adjuvant. The Company is focused on research and development (R&D) programs, as well as holds investment in product candidates and commercial products.